Insights | Corona Virus & Vitiligo | What is Vitiligo | World Vitiligo Day

Vitiligo stories

22 January 2024

Colour change: From Dark to White Paul Monteiro’s Story

Paul Monteiro has had vitiligo since he was twelve years…

VIPOC 0

Love0

Events

12 January 2024

Vitiligo, Educate, Inspire, Support SXM – VEISS 2nd annual mini-conference- ST MAARTEN 1st – 3rd December 2023

The second conference organized by VEISS association took place around…

VIPOC 0

Love1

News

8 December 2023

Vitiligo and Us Comic Book

The French Vitiligo Association is delighted to unveil its inaugural…

VIPOC 0

Love0

Events

28 November 2023

Navigating the Journey of Vitiligo: Insights from the European Health Congress 2023 in Munich

Introduction: The European Health Congress 2023, held in Munich, served…

VIPOC 0

Love0

News

23 November 2023

Doctors’ training on vitiligo in the D.R.C

The Association Franco-Congolaise du Vitiligo (AFCV), which was created in…

VIPOC 0

Love0

Events

21 November 2023

The European Academy of Dermatology and Venereology 2023

The European Academy of Dermatology and Venereology convened this year…

VIPOC 0

Love0

Vitiligo stories

20 November 2023

Mr Stephen Taylor, an active 63-year-old African American who’s not just counting his years but making them count

Meet Mr Stephen Taylor, an active 63-year-old African American who's…

VIPOC 0

Love0

Vitiligo research

17 November 2023

Dermatologists Answer Your Top Vitiligo Questions

Living with vitiligo can mean navigating through plenty of unanswered…

VIPOC 0

Love0

Quality of Life with Vitiligo

20 October 2023

Unveiling the Unseen Struggles: A Comprehensive Review of Vitiligo’s Psychological, Social, and Quality of Life Impacts

Abstract This review explores the psychosocial impact of vitiligo on…

VIPOC 0

Love0

- Study phase 2 Abbvie -UPADACITINIB News

20 October 2023

Upadacitinib Meets Primary End Point of Phase 2 Trial for Vitiligo and Advances to Phase 3

AbbVie recently announced that its phase 2b study investigating upadacitinib (Rinvoq)…

VIPOC 0

Love0